Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. (2018)
Attributed to:
EPICure@19 - the extremely preterm young adult
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-021944
PubMed Identifier: 30166303
Publication URI: http://europepmc.org/abstract/MED/30166303
Type: Journal Article/Review
Volume: 8
Parent Publication: BMJ open
Issue: 8
ISSN: 2044-6055